TIG Advisors LLC’s Pfizer PFE Stock Holding History

TIG Advisors LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-183,397	Closed	-$5.54M	–	61
2023 Q3	$6.08M	Buy	+183,397	New	+$6.49M	0.27%	25
2016 Q2	–	Sell	-195,001	Closed	-$5.48M	–	43
2016 Q1	$5.48M	Buy	+195,001	New	+$5.57M	0.26%	37

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

TIG Advisors LLC's PFE Position: Q4 2023 in Review

TIG Advisors LLC sold out of Pfizer (PFE) in Q4 2023, closing a stake of 183,397 shares — an estimated $5.54M sold.

TIG Advisors LLC first reported a position in PFE in Q1 2016 and held it in 2 quarters. The position peaked at $6.08M in Q3 2023. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

TIG Advisors LLC reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
TIG Advisors LLC sold 183,397 Pfizer shares in Q4 2023, an estimated $5.54M.
TIG Advisors LLC first reported a position in Pfizer in Q1 2016 and held it in 2 quarters.
TIG Advisors LLC's Pfizer position peaked at $6.08M in Q3 2023.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on TIG Advisors LLC's 13F filing for Q4 2023, filed 14 Feb 2024.